Literature DB >> 4749374

Natural course of inoperable lung cancer.

L Hyde, J Wolf, S McCracken, R Yesner.   

Abstract

Entities:  

Mesh:

Year:  1973        PMID: 4749374     DOI: 10.1378/chest.64.3.309

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  17 in total

1.  Economic and quality-of-life aspects of treating small cell lung cancer.

Authors:  P Graham; J Boyages
Journal:  Pharmacoeconomics       Date:  1993-06       Impact factor: 4.981

2.  Management of lung cancer.

Authors:  S Costello; F Macbeth
Journal:  BMJ       Date:  1991-02-02

3.  Performance and prognosis in patients with lung cancer. The Edinburgh Lung Cancer Group.

Authors:  S Capewell; M F Sudlow
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

4.  Comparisons of exercise dose and symptom severity between exercisers and nonexercisers in women during and after cancer treatment.

Authors:  Maria H Cho; Marylin J Dodd; Bruce A Cooper; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2012-03-19       Impact factor: 3.612

Review 5.  Lung cancer--current concepts and controversies.

Authors:  S B Pett; J A Wernly; B F Akl
Journal:  West J Med       Date:  1986-07

6.  The combined modality approach in the treatment of inoperable small-cell anaplastic carcinoma of the lung.

Authors:  R Osieka; C G Schmidt; H B Makoski; E Scherer
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-05-20

7.  Prognostic factors for survival in terminal lung cancer patients.

Authors:  R S Schonwetter; B E Robinson; G Ramirez
Journal:  J Gen Intern Med       Date:  1994-07       Impact factor: 5.128

8.  Women with lung cancer: impact on quality of life.

Authors:  L Sarna
Journal:  Qual Life Res       Date:  1993-02       Impact factor: 4.147

9.  The effect of symptom clusters on functional status and quality of life in women with breast cancer.

Authors:  Marylin J Dodd; Maria H Cho; Bruce A Cooper; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2009-11-07       Impact factor: 2.398

Review 10.  Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; M Clerici; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.